Barbut_edit.qxp 16/7/08 10:54 am Page 128
Infection Control and Prevention
epidemiologists, members of the environmental services department include isolation and treatment of infected patients and
and hospital administrators. Restrictive and appropriate use of implementation of contact precautions. Attention must be given to
antibiotics is of huge importance to prevent the emergence of CDI. glove use, hand washing and environment disinfection. Surveillance
Prevention of cross-infection requires a constant awareness of should be instituted in order to immediately detect outbreaks. Many
CDI among practitioners. C. difficile testing should be performed for outbreaks have been controlled by an integrated interdisciplinary
every unexplained case of nosocomial diarrhoea. Control measures programme only.
60
■
1. Kelly CP, Pothoulakis C, LaMont JT, Clostridium difficile colitis, epidemic of Clostridium difficile-associated disease caused by Hand Hygiene Task Force, Infect Control Hosp Epidemiol, 2002;
N Engl J Med, 1994;330(4):257–62. the hypervirulent NAP1/027 strain, Clin Infect Dis, 2007;45 23(Suppl. 12):S3–40.
2. McFarland LV, Mulligan ME, Kwok RY, Stamm WE, Nosocomial (Suppl. 2):S112–21. 41. Weber DJ, Sickbert-Bennett E, Gergen MF, Rutala WA, Efficacy
acquisition of Clostridium difficile infection, N Engl J Med, 1989; 23. Dellit TH, Owens RC, McGowan JE Jr, et al., Infectious Diseases of selected hand hygiene agents used to remove Bacillus
320(4):204–10. Society of America and the Society for Healthcare Epidemiology atrophaeus (a surrogate of Bacillus anthracis) from contaminated
3. Mylonakis E, Ryan ET, Calderwood SB, Clostridium difficile – of America guidelines for developing an institutional program to hands, JAMA, 2003;289(10):1274–7.
Associated diarrhea: A review, Arch Intern Med, 2001;161(4): enhance antimicrobial stewardship, Clin Infect Dis, 2007;44(2): 42. Leischner et al., Interscience Conference on Antimicrobial
525–33. 159–77. Agents and Chemotherapy 2005, abstract LB29.
4. Loo VG, Poirier L, Miller MA, et al., A Predominantly Clonal 24. Delmee M, Laboratory diagnosis of Clostridium difficile disease, 43. Boyce JM, Ligi C, Kohan C, et al., Lack of association
Multi-Institutional Outbreak of Clostridium difficile-Associated Clin Microbiol Infect, 2001;7(8):411–16. between the increased incidence of Clostridium difficile-
Diarrhea with High Morbidity and Mortality, N Engl J Med, 25. Barbut F, Delmee M, Brazier JS, et al., A European survey of associated disease and the increasing use of alcohol-based
2005;353:2442–9. diagnostic methods and testing protocols for Clostridium hand rubs, Infect Control Hosp Epidemiol, 2006;27(5):
5. McDonald LC, Killgore GE, Thompson A, et al., An Epidemic, difficile, Clin Microbiol Infect, 2003;9(10):989–96. 479–83.
Toxin Gene-Variant Strain of Clostridium difficile, N Engl J Med, 26. Kuijper E, Coignard B, Tull P, Emergence of Clostridium difficile- 44. Barbut F, Gotty S, Magne S, et al., Clostridium difficile:
2005;353:2433–41. associated disease in North America and Europe, Clin Microbiol hygiène des mains et environnement, Hygiènes, 2003;6:
6. Kuijper EJ, Coignard B, Brazier JS, et al., Update of Clostridium Infect, 2006;12(Supp. 6):2–18. 449–55.
difficile-associated disease due to PCR ribotype 027 in Europe, 27. Barbut F, Lalande V, Burghoffer B, et al., Prevalence and 45. Riggs MM, Sethi AK, Zabarsky TF, et al., Asymptomatic carriers
Euro Surveill, 2007;12(6):E1–2. genetic characterization of toxin A variant strains of Clostridium are a potential source for transmission of epidemic and
7. Pepin J, Valiquette L, Alary ME, et al., Clostridium difficile- difficile among adults and children with diarrhea in France, nonepidemic Clostridium difficile strains among long-term care
associated diarrhea in a region of Quebec from 1991 to 2003: J Clin Microbiol, 2002;40(6):2079–83. facility residents, Clin Infect Dis, 2007;45(8):992–8.
a changing pattern of disease severity, CMAJ, 2004;171(5): 28. Kato H, Kato N, Watanabe K, et al., Identification of toxin 46. Kim KH, Fekety R, Batts DH, et al., Isolation of Clostridium
466–72. A-negative, toxin B-positive Clostridium difficile by PCR, J Clin difficile from the environment and contacts of patients with
8. Bartlett JG, Clinical practice. Antibiotic-associated diarrhea, Microbiol, 1998;36(8):2178–82. antibiotic-associated colitis, J Infect Dis, 1981;143(1):42–50.
N Engl J Med, 2002;346(5):334–9. 29. Belanger SD, Boissinot M, Clairoux N, et al., Rapid detection of 47. Verity P, Wilcox MH, Fawley W, Parnell P, Prospective
9. Spencer RC, The role of antimicrobial agents in the aetiology of Clostridium difficile in feces by real-time PCR, J Clin Microbiol, evaluation of environmental contamination by Clostridium
Clostridium difficile-associated disease, J Antimicrob Chemother, 2003;41(2):730–34. difficile in isolation side rooms, J Hosp Infect, 2001;49(3):
1998;41(Suppl. C):21–7. 30. van den Berg RJ, Vaessen N, Endtz HP, et al., Evaluation of 204–9.
10. Severe Clostridium difficile-associated disease in populations real-time PCR and conventional diagnostic methods for the 48. Kramer A, Schwebke I, Kampf G, How long do nosocomial
previously at low risk – four states, 2005, MMWR Morb Mortal detection of Clostridium difficile-associated diarrhoea in a pathogens persist on inanimate surfaces? A systematic review,
Wkly Rep, 2005;54(47):1201–5. prospective multicentre study, J Med Microbiol, 2007;56 BMC Infect Dis, 2006;6:130.
11. Surveillance for community-associated Clostridium difficile— (Pt 1):36–42. 49. Wilcox MH, Fawley WN, Wigglesworth N, et al., Detergent
Connecticut, 2006, MMWR Morb Mortal Wkly Rep, 2008;57(13): 31. Peterson LR, Manson RU, Paule SM, et al., Detection of versus hypochlorite cleaning and Clostridium difficile infection,
340–43. toxigenic Clostridium difficile in stool samples by real-time J Hosp Infect 2004;56(4):331.
12. Wilcox MH, Mooney L, Bendall R, et al., A case-control study of polymerase chain reaction for the diagnosis of C. difficile- 50. Apisarnthanarak A, Zack JE, Mayfield JL, et al., Effectiveness of
community-associated Clostridium difficile infection, associated diarrhea, Clin Infect Dis, 2007;45(9):1152–60. environmental and infection control programs to reduce
J Antimicrob Chemother, 2008; Epub ahead of print. 32. Johnson S, Gerding DN, Olson MM, et al., Prospective, transmission of Clostridium difficile, Clin Infect Dis, 2004;39(4):
13. Aslam S, Hamill RJ, Musher DM, Treatment of Clostridium controlled study of vinyl glove use to interrupt Clostridium 601–2.
difficile-associated disease: old therapies and new strategies, difficile nosocomial transmission, Am J Med, 1990;88(2): 51. Mayfield JL, Leet T, Miller J, Mundy LM, Environmental control
Lancet Infect Dis, 2005;5(9):549–57. 137–40. to reduce transmission of Clostridium difficile, Clin Infect Dis,
14. Musher DM, Aslam S, Logan N, et al., Relatively poor outcome 33. Brooks SE, Veal RO, Kramer M, et al., Reduction in the incidence 2000;31(4):995–1000.
after treatment of Clostridium difficile colitis with of Clostridium difficile-associated diarrhea in an acute care 52. McMullen KM, Zack J, Coopersmith CM, et al., Use of
metronidazole, Clin Infect Dis, 2005;40(11):1586–90. hospital and a skilled nursing facility following replacement of hypochlorite solution to decrease rates of Clostridium difficile-
15. Popoff MR, Rubin EJ, Gill DM, Boquet P, Actin-specific ADP- electronic thermometers with single-use disposables, Infect associated diarrhea, Infect Control Hosp Epidemiol, 2007;28(2):
ribosyltransferase produced by a Clostridium difficile strain, Control Hosp Epidemiol, 1992;13(2):98–103. 205–7.
Infect Immun, 1988;56(9):2299–2306. 34. Fekety R, Guidelines for the diagnosis and management of 53. Réseau d’Alerte d’Investigation et de Surveillance des Infections
16. Akerlund T, Persson I, Unemo M, et al., Increased sporulation Clostridium difficile-associated diarrhea and colitis. American Nosocomiales. Conduite à tenir : diagnostic, surveillance,
rate of epidemic Clostridium difficile Type 027/NAP1, J Clin College of Gastroenterology, Practice Parameters Committee, investigation, prévention et contrôle des infections à Clostridium
Microbiol, 2008;46(4):1530–33. Am J Gastroenterol, 1997;92(5):739–50. difficile, Institut de Veille Sanitaire, 2006.
17. Warny M, Pepin J, Fang A, et al., Toxin production by an 35. Wullt M, Odenholt I, Walder M, Activity of three disinfectants 54. Eckstein BC, Adams DA, Eckstein EC, et al., Reduction of
emerging strain of Clostridium difficile associated with and acidified nitrite against Clostridium difficile spores, Infect Clostridium difficile and vancomycin-resistant Enterococcus
outbreaks of severe disease in North America and Europe, Control Hosp Epidemiol, 2003;24(10):765–8. contamination of environmental surfaces after an intervention
Lancet, 2005;366(9491):1079–84. 36. Dudley MN, McLaughlin JC, Carrington G, et al., Oral bacitracin to improve cleaning methods, BMC Infect Dis, 2007;7:61.
18. Anand A, Glatt AE, Clostridium difficile infection associated vs vancomycin therapy for Clostridium difficile-induced diarrhea, 55. Boyce et al., Independent Safety Hygiene Environment
with antineoplastic chemotherapy: a review, Clin Infect Dis, A randomized double-blind trial, Arch Intern Med, 1986;146(6): Associates 2006, abstract 199.
1993;17(1):109–13. 1101–4. 56. Menuet et al., European Congress of Clinical Microbiology and
19. Biller P, Shank B, Lind L, et al., Moxifloxacin therapy as a risk 37. Surawicz CM, McFarland LV, Greenberg RN, et al., The search Infectious Diseases 2008, abstract 0466.
factor for Clostridium difficile-associated disease during an for a better treatment for recurrent Clostridium difficile disease: 57. Roberts K, Smith CF, Snelling AM, et al., Aerial dissemination of
outbreak: attempts to control a new epidemic strain, Infect use of high-dose vancomycin combined with Saccharomyces Clostridium difficile spores, BMC Infect Dis, 2008;8:7.
Control Hosp Epidemiol, 2007;28(2):198–201. boulardii, Clin Infect Dis, 2000;31(4):1012–17. 58. Shim JK, Johnson S, Samore MH, et al., Primary symptomless
20. Pepin J, Saheb N, Coulombe MA, et al., Emergence of 38. Samore MH, Venkataraman L, DeGirolami PC, et al., Clinical colonisation by Clostridium difficile and decreased risk of
fluoroquinolones as the predominant risk factor for Clostridium and molecular epidemiology of sporadic and clustered cases of subsequent diarrhoea, Lancet, 1998;351(9103):633–6.
difficile-associated diarrhea: a cohort study during an epidemic nosocomial Clostridium difficile diarrhea, Am J Med, 1996; 59. Johnson S, Homann SR, Bettin KM, et al., Treatment of
in Quebec, Clin Infect Dis, 2005;41(9):1254–60. 100(1):32–40. asymptomatic Clostridium difficile carriers (fecal excretors) with
21. Thomas C, Riley TV, Restriction of third generation 39. Struelens MJ, Maas A, Nonhoff C, et al., Control of nosocomial vancomycin or metronidazole, A randomized, placebo-
cephalosporin use reduces the incidence of Clostridium difficile- transmission of Clostridium difficile based on sporadic case controlled trial, Ann Intern Med, 1992;117(4):297–302.
associated diarrhoea in hospitalised patients, Commun Dis Intell, surveillance, Am J Med, 1991;91(3B):138S–44S. 60. Zafar AB, Gaydos LA, Furlong WB, et al., Effectiveness of
2003;(Suppl. 27):S28–31. 40. Boyce JM, Pittet D, Guideline for Hand Hygiene in Health-Care infection control program in controlling nosocomial Clostridium
22. Valiquette L, Cossette B, Garant MP, et al., Impact of a Settings: recommendations of the Healthcare Infection Control difficile, Am J Infect Control, 1998;26(6):588–93.
reduction in the use of high-risk antibiotics on the course of an Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA
128 EUROPEAN INFECTIOUS DISEASE
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132